• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

APIS: a software for model identification, simulation and dosage regimen calculations in clinical and experimental pharmacokinetics.

作者信息

Iliadis A, Brown A C, Huggins M L

机构信息

INSERM U278, Faculté de Pharmacie, Marseille, France.

出版信息

Comput Methods Programs Biomed. 1992 Aug;38(4):227-39. doi: 10.1016/0169-2607(92)90103-e.

DOI:10.1016/0169-2607(92)90103-e
PMID:1473342
Abstract

APIS is a software package based on mathematical modelling which provides a reliable approach in optimizing drug therapy. It was designed to assist clinicians in interpreting blood drug levels so that drug therapy may be better and more cost-effective. It is a methodological approach to describe, predict and control the kinetic behaviour of a drug. This software incorporates the principle of Bayesian procedures, i.e. one can use all available patient information (population) to determine patient-specific parameter estimates. These estimates can then be used to design an optimal and individualized drug regimen. APIS is an attractive and useful tool for clinical and experimental pharmacokinetics. APIS may be used on any IBM compatible computer using the Microsoft-Windows environment. The software is menu driven to provide a very user-friendly tool for analysing pharmacokinetic data and for designing dosage regimens.

摘要

相似文献

1
APIS: a software for model identification, simulation and dosage regimen calculations in clinical and experimental pharmacokinetics.
Comput Methods Programs Biomed. 1992 Aug;38(4):227-39. doi: 10.1016/0169-2607(92)90103-e.
2
Pharmacokinetics and dosage regimens of amikacin in intensive care unit patients.重症监护病房患者中阿米卡星的药代动力学及给药方案
Int J Biomed Comput. 1994 Jun;36(1-2):135-7. doi: 10.1016/0020-7101(94)90105-8.
3
Abbott PKS system: a new version for applied pharmacokinetics including Bayesian estimation.
Int J Biomed Comput. 1994 Jun;36(1-2):127-30. doi: 10.1016/0020-7101(94)90103-1.
4
[Validation of a new interactive software monitoring a controlled-flow infusion pump for cisplatin dosage regimen adjustment].
Bull Cancer. 1996 Aug;83(8):664-76.
5
Progress in strategies for dosage regimen individualization.剂量方案个体化策略的进展。
Curr Top Med Chem. 2012;12(15):1669-77. doi: 10.2174/156802612803531315.
6
Predictive performance of two software packages (USC*PACK PC and Abbott PKS system) for the individualization of amikacin dosage in intensive care unit patients.两种软件包(USC*PACK PC和雅培PKS系统)对重症监护病房患者阿米卡星剂量个体化的预测性能。
Int J Biomed Comput. 1994 Jun;36(1-2):131-4. doi: 10.1016/0020-7101(94)90104-x.
7
Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients.危重症患者阿米卡星剂量个体化的群体药代动力学模型评估
J Pharm Pharmacol. 2009 Jun;61(6):759-66. doi: 10.1211/jpp/61.06.0008.
8
Application of Bayesian estimation for the prediction of an appropriate dosage regimen of amikacin.
J Pharm Sci. 1989 Sep;78(9):753-7. doi: 10.1002/jps.2600780911.
9
Population kinetics and conditional assessment of the optimal dosage regimen using the P-PHARM software package.使用P-PHARM软件包进行群体药代动力学及最佳给药方案的条件评估。
Anticancer Res. 1994 Nov-Dec;14(6A):2321-6.
10
MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring.
Comput Biol Med. 1992 May;22(3):155-63. doi: 10.1016/0010-4825(92)90011-b.

引用本文的文献

1
Adaptive dosing of high-dose busulfan in real-world adult patients undergoing haematopoietic cell transplant conditioning.造血细胞移植预处理的成年患者中高剂量白消安的适应性给药
Br J Clin Pharmacol. 2025 Apr;91(4):1171-1181. doi: 10.1111/bcp.16343. Epub 2024 Nov 20.
2
Kinetic nomograms assist individualization of drug regimens.动力学列线图有助于药物方案的个体化。
Clin Pharmacokinet. 2011 Dec 1;50(12):773-9. doi: 10.2165/11594000-000000000-00000.
3
Severe acute toxicity associated with high-dose methotrexate (MTX) therapy: use of therapeutic drug monitoring and test-dose to guide carboxypeptidase G2 rescue and MTX continuation.
与高剂量甲氨蝶呤(MTX)治疗相关的严重急性毒性:使用治疗药物监测和试验剂量指导羧肽酶G2解救及MTX继续治疗。
Eur J Clin Pharmacol. 2007 Jan;63(1):39-42. doi: 10.1007/s00228-006-0212-1. Epub 2006 Nov 18.
4
Development of stealth liposome formulation of 2'-deoxyinosine as 5-fluorouracil modulator: in vitro and in vivo study.2'-脱氧肌苷作为5-氟尿嘧啶调节剂的隐形脂质体制剂的研发:体外和体内研究
Pharm Res. 2005 Dec;22(12):2051-7. doi: 10.1007/s11095-005-8355-9. Epub 2005 Oct 21.
5
Dose-dependent resorption of quinine after intrarectal administration to children with moderate Plasmodium falciparum malaria.对中度恶性疟原虫疟疾患儿直肠内给予奎宁后,奎宁的剂量依赖性吸收。
Antimicrob Agents Chemother. 2004 Nov;48(11):4422-6. doi: 10.1128/AAC.48.11.4422-4426.2004.
6
Quinine distribution in mice with Plasmodium berghei malaria.伯氏疟原虫感染小鼠体内奎宁的分布情况。
Eur J Drug Metab Pharmacokinet. 2003 Jan-Mar;28(1):11-20. doi: 10.1007/BF03190862.
7
Intrarectal pharmacokinetics of two formulations of quinine in children with falciparum malaria.两种奎宁制剂在恶性疟患儿直肠内的药代动力学
Eur J Clin Pharmacol. 2003 Feb;58(10):649-52. doi: 10.1007/s00228-002-0546-2. Epub 2003 Jan 29.
8
Information tools for exploratory data analysis in population pharmacokinetics.
J Pharmacokinet Pharmacodyn. 2001 Dec;28(6):577-99. doi: 10.1023/a:1014464505261.
9
Efficacy of trovafloxacin against penicillin-susceptible and multiresistant strains of Streptococcus pneumoniae in a mouse pneumonia model.曲伐沙星在小鼠肺炎模型中对青霉素敏感和多重耐药肺炎链球菌菌株的疗效。
Antimicrob Agents Chemother. 1998 Apr;42(4):862-7. doi: 10.1128/AAC.42.4.862.
10
Efficacy of single-dose ceftriaxone in experimental otitis media induced by penicillin- and cephalosporin-resistant Streptococcus pneumoniae.单剂量头孢曲松对青霉素和头孢菌素耐药肺炎链球菌所致实验性中耳炎的疗效
Antimicrob Agents Chemother. 1996 Sep;40(9):1977-82. doi: 10.1128/AAC.40.9.1977.